Physician profile
Harold German
NPI 1063591220
$1,276.07
in general payments reported to CMS, 2019-2025
16 companies · $73.51 in 2025
The $73.51 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $33.81 · 2021: $305 · 2022: $193 · 2023: $104 · 2024: $42.41 · 2025: $73.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.84 | 2019-2022 | |
| Pfizer INC. | $223.08 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $136.38 | 2019-2021 | |
| Glaxosmithkline, LLC. | $130.22 | 2021-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $86.10 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $71.49 | 2019 | |
| Abbvie INC. | $64.27 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.48 | 2019 | |
| Nevro Corp. | $32.05 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.32 | 2025 | |
| Althera Pharmaceuticals LLC | $24.54 | 2021 | |
| Mylan Specialty L.P. | $23.23 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.74 | 2019 | |
| Dynavax Technologies Corporation | $19.43 | 2023 | Heplisav-B |
| Opko Pharmaceuticals, LLC | $11.95 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold German listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.